A conversation with Ben Fairfax about the recent article: CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade.
CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade
Loading Video...
This episode discusses Milotay, G., Little, M., Watson, R.A. et al. CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade. Nat Med (2025). https://doi.org/10.1038/s41591-025-03647-1.
Series:
People:
Oxford Unit:
Keywords:
More in this Series...
In a series produced by the Oxford Immunology Network, Professor Paul Klenerman talks with colleagues about their recent ground-breaking publications, exploring the original scientific goals, challenges they encountered along the way, and future ambitions in the field. This series will be of interest to anyone studying or working in immunology, medical sciences, biology or related fields.
NB: To Immunity and Beyond is for educational purposes only and should not be considered...